Literature DB >> 3670904

Are sex, age at diagnosis, or mode of presentation prognostic factors for cystic fibrosis?

I Hudson1, P D Phelan.   

Abstract

Data on 622 patients with cystic fibrosis born in Victoria, Australia from 1955 to 1980 and on 344 surviving patients in the care of a specialist clinic on June 30, 1983 were analyzed for factors associated with better survival and a less rapid progress of lung disease. Presentation with predominantly gastrointestinal symptoms, other than meconium ileus, was associated with an improved prognosis, whereas presentation with predominantly respiratory symptoms was associated with a worse prognosis. While infants diagnosed before the age of 6 months as a result of routine testing because of a family history of the disease seemed to have less rapid progress of lung disease, their ultimate survival did not seem to be better than that of patients presenting symptomatically after the newborn period. The sex of the patients did not appear to have prognostic significance. Age at diagnosis did not affect rate of progress of lung disease or survival when infants dying within 6 months of birth were excluded. There was a close association between the extent of lung disease at diagnosis and current lung disease. Failure to reverse extensive disease at diagnosis or deterioration of lung disease in the first year after diagnosis was associated with a less favourable course.

Entities:  

Mesh:

Year:  1987        PMID: 3670904     DOI: 10.1002/ppul.1950030503

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  10 in total

1.  A prognostic model for the prediction of survival in cystic fibrosis.

Authors:  K M Hayllar; S G Williams; A E Wise; S Pouria; M Lombard; M E Hodson; D Westaby
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

2.  Effects of social class, sex, and region of residence on age at death from cystic fibrosis.

Authors:  J R Britton
Journal:  BMJ       Date:  1989-02-25

3.  Phenotypic conversion of Pseudomonas aeruginosa in cystic fibrosis.

Authors:  M Fegan; P Francis; A C Hayward; G H Davis; J A Fuerst
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

4.  Neonatal screening for cystic fibrosis.

Authors:  P D Phelan
Journal:  Thorax       Date:  1995-07       Impact factor: 9.139

5.  Wasting as an independent predictor of mortality in patients with cystic fibrosis.

Authors:  R Sharma; V G Florea; A P Bolger; W Doehner; N D Florea; A J Coats; M E Hodson; S D Anker; M Y Henein
Journal:  Thorax       Date:  2001-10       Impact factor: 9.139

6.  Long-term follow-up of distal intestinal obstruction syndrome in cystic fibrosis.

Authors:  Moran Lavie; Tzipora Manovitz; Daphna Vilozni; Sarina Levy-Mendelovich; Ifat Sarouk; Ilana Weintraubv; David Shoseyov; Malena Cohen-Cymberknoh; Joseph Rivlin; Ori Efrati
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

7.  Heart-lung transplantation for cystic fibrosis. 1: Assessment.

Authors:  B Whitehead; P Helms; M Goodwin; I Martin; B Lask; E Serrano; J P Scott; R L Smyth; T W Higenbottam; J Wallwork
Journal:  Arch Dis Child       Date:  1991-09       Impact factor: 3.791

Review 8.  The relationship between atopy and cystic fibrosis.

Authors:  R W Wilmott
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

9.  Cystic fibrosis: the delta F508 mutation does not lead to an exceptionally severe phenotype. A cohort study.

Authors:  G Borgo; P Gasparini; A Bonizzato; G Cabrini; G Mastella; P F Pignatti
Journal:  Eur J Pediatr       Date:  1993-12       Impact factor: 3.183

10.  [Early manifestations of cystic fibrosis in a premature patient with complex meconium ileus at birth].

Authors:  Ieda Regina Lopes del Ciampo; Tainara Queiroz Oliveira; Luiz Antonio del Ciampo; Regina Sawamura; Lidia Alice Gomes Monteiro Marin Torres; Albin Eugenio Augustin; Maria Inez Machado Fernandes
Journal:  Rev Paul Pediatr       Date:  2015-03-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.